Literature DB >> 19115504

[Gingival fibromatosis (hereditary hyperplastic gingivitis) in a wild European red fox (Vulpes vulpes)].

C Schulze1, M Bensch, N Winterhoff, H Ansorge, J P Teifke.   

Abstract

This report describes a case of gingival fibromatosis in an otherwise healthy and well nourished wild European red fox (Vulpes vulpes), which was shot by a hunter and submitted to the state laboratory in the context of the rabies monitoring program of the federal state of Brandenburg, Germany. At necropsy, a severe papillomatous proliferation of the complete gingival tissue of the upper and lower jaw was present. This gingival proliferation had already resulted in malocclusion, loosening and loss of several incisival, premolar and molar teeth. Histologically, the primary lesion was a massive increase in the amount of collagen rich and relatively avascular connective tissue within the gingival lamina propria mucosae. A papillomavirus infection was excluded by electron microscopy, immunohistochemistry and molecular biological methods. The gingival lesions in the red fox are identical to those seen in hereditary hyperplastic gingivitis in farmed silver foxes and hereditary gingival fibromatosis in man. It is presumed that, in analogy to the genetic diseases in silver foxes and man, a still unidentified genetic defect is responsible for the development of the disease in the red fox, too.

Entities:  

Mesh:

Year:  2008        PMID: 19115504

Source DB:  PubMed          Journal:  Dtsch Tierarztl Wochenschr        ISSN: 0341-6593


  2 in total

1.  Hereditary hyperplastic gingivitis in North American farmed silver fox (Vulpes vulpes).

Authors:  Jo-Anna B J Clark; Robert C Hudson; H Dawn Marshall
Journal:  Can Vet J       Date:  2015-04       Impact factor: 1.008

2.  Sequence analysis of the Ras-MAPK pathway genes SOS1, EGFR & GRB2 in silver foxes (Vulpes vulpes): candidate genes for hereditary hyperplastic gingivitis.

Authors:  Jo-Anna B J Clark; Sara J Tully; H Dawn Marshall
Journal:  Genetica       Date:  2014-11-07       Impact factor: 1.082

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.